Skip to content
Home
Leadership
Locations
Careers
Investors
Media
Press Releases
SEC Filings
Governance
Board Committee
Board of Directors
Governance Documents
Investor Relations Contacts
Investor Materials
Analyst Coverage
Benchmark – Bill Sutherland
Maxim Group – Anthony Vendetti
Freedom Capital Markets – Gene Mannheimer
Contact
Nutex Health
Home
Leadership
Locations
Careers
Investors
Media
Press Releases
SEC Filings
Governance
Board Committee
Board of Directors
Governance Documents
Investor Relations Contacts
Investor Materials
Analyst Coverage
Benchmark – Bill Sutherland
Maxim Group – Anthony Vendetti
Freedom Capital Markets – Gene Mannheimer
Contact
Posts in November 2022
by
919496pwpadmin
November 22, 2022
NUTEX HEALTH to present at the benchmark company’s upcoming discovery one-on-one investor conference
HOUSTON, Nov. 22, 2022 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), […]
0
read more
by
919496pwpadmin
November 22, 2022
NUTEX HEALTH REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND ANNOUNCES COMMON STOCK PURCHASE AGREEMENT FOR A COMMITMENT TO PURCHASE UP TO $100 MILLION WORTH OF SHARES OF ITS COMMON STOCK WITH LINCOLN PARK CAPITAL
NET CASH FROM OPERATING ACTIVITIES OF $46.1 MILLION FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022 […]
0
read more
